id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-320499-76o2zj0v	Davoodi, Lotfollah	Hydroxychloroquine-induced Stevens–Johnson syndrome in COVID-19: a rare case report	2020-06-25		.txt	text/plain	1385	80	51	One such medication includes the antimalarial hydroxychloroquine (HCQ), which recently reported as a possible therapy for shortening the duration of COVID-19 symptoms, reducing inflammatory reactions to infection, impairing the exacerbation of pneumonia and boosting lung imaging findings. Here, we report on the case of a 42-year-old woman, presented with fever and dry cough, who had COVID-19 and 2 days later presented with a pruritic erythematous maculopapular rash, which started from the distal of upper extremities and rapidly, involved the entire body. One of the drugs prescribed to improve the condition of COVID-19 patients is the antimalarial hydroxychloroquine (HCQ), which recently reported as a supportive drug for shortening the duration of COVID-19 symptoms, reducing inflammatory reactions to infection, impairing the exacerbation of pneumonia and boosting lung imaging findings [3] .	./cache/cord-320499-76o2zj0v.txt	./txt/cord-320499-76o2zj0v.txt